Inhibition of human immunodeficiency virus type 1 replication in human cells by debio-025, a novel cyclophilin binding agent

RG Ptak, PA Gallay, D Jochmans, AP Halestrap, UT Ruegg, LA Pallansch, MD Bobardt, M-P de Béthune, J Neyts, E De Clercq, J-M Dumont, P Scalfaro, K Besseghir, RM Wenger, B Rosenwirth

Research output: Contribution to journalArticle (Academic Journal)

85 Citations (Scopus)
Translated title of the contributionInhibition of human immunodeficiency virus type 1 replication in human cells by debio-025, a novel cyclophilin binding agent
Original languageEnglish
Pages (from-to)1302 - 1317
Number of pages16
JournalAntimicrobial Agents and Chemotherapy
Volume52 (4)
DOIs
Publication statusPublished - Apr 2008

Cite this

Ptak, RG., Gallay, PA., Jochmans, D., Halestrap, AP., Ruegg, UT., Pallansch, LA., Bobardt, MD., de Béthune, M-P., Neyts, J., De Clercq, E., Dumont, J-M., Scalfaro, P., Besseghir, K., Wenger, RM., & Rosenwirth, B. (2008). Inhibition of human immunodeficiency virus type 1 replication in human cells by debio-025, a novel cyclophilin binding agent. Antimicrobial Agents and Chemotherapy, 52 (4), 1302 - 1317. https://doi.org/10.1128/AAC.01324-07